:

Li Guo1,2, Zhen-Zhen Hao1,2, Qian Zhang1,2

  • 1Department of Nephrology, Affiliated Hospital of HeBei University, No. 212 of YuHua East Road, LianChi District, Baoding, 071000, Hebei, China.

Open life sciences
|November 26, 2024
PubMed
概括

这项研究报告了一例药物诱导的球小血管病变 (GMA) 病例,患者接受了tislelizumab和fruquintinib治疗. 迅速治疗导致了患者的康复,强调了监测药物诱导的损伤的重要性.